Caseware UK (AP4) 2023.0.135 2023.0.135 2025-01-312025-01-31truetrue2024-02-012No description of principal activity2falsetrue 09958042 2024-02-01 2025-01-31 09958042 2023-02-01 2024-01-31 09958042 2025-01-31 09958042 2024-01-31 09958042 c:Director1 2024-02-01 2025-01-31 09958042 d:CurrentFinancialInstruments 2025-01-31 09958042 d:CurrentFinancialInstruments 2024-01-31 09958042 d:ShareCapital 2025-01-31 09958042 d:ShareCapital 2024-01-31 09958042 c:OrdinaryShareClass1 2024-02-01 2025-01-31 09958042 c:OrdinaryShareClass1 2025-01-31 09958042 c:OrdinaryShareClass1 2024-01-31 09958042 c:EntityHasNeverTraded 2024-02-01 2025-01-31 09958042 c:FRS102 2024-02-01 2025-01-31 09958042 c:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 09958042 c:FullAccounts 2024-02-01 2025-01-31 09958042 c:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09958042 e:PoundSterling 2024-02-01 2025-01-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09958042









THE SUTTON IMPLANT CLINIC LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JANUARY 2025

 
THE SUTTON IMPLANT CLINIC LIMITED
REGISTERED NUMBER: 09958042

BALANCE SHEET
AS AT 31 JANUARY 2025

2025
2024
Note
£
£

  

Current assets
  

Debtors: amounts falling due within one year
 4 
100
100

  
100
100

Total assets less current liabilities
  
 
 
100
 
 
100

  

Net assets
  
100
100


Capital and reserves
  

Called up share capital 
 5 
100
100

  
100
100


For the year ended 31 January 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 25 February 2025.




Dr P Jain
Director

The notes on page 2 form part of these financial statements.

Page 1

 
THE SUTTON IMPLANT CLINIC LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 09958042.  The Company's registered office is 60 Birmingham Road, Sutton Coldfield, B72 1QP.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.


3.


Employees




The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Debtors

2025
2024
£
£


Called up share capital not paid
100
100

100
100



5.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100


Page 2